Pfizer Uk
- All
- News
- Videos
-
UK Approves Covid Jab For Under-12s As New Daily Cases Top 1 Lakh
British regulators on Wednesday approved Pfizer's Covid-19 vaccine for use in children aged five to 11, as the country reported more than 100,000 new daily cases for the first time as Omicron surged.
-
Mixing Covid Vaccines Is Effective In Study on Pfizer, AstraZeneca
Mixing other vaccines with those from AstraZeneca Plc or Pfizer Inc. offers at least as effective protection against Covid-19 as giving two doses of the same shots, a UK study found.
-
UK Schoolchildren Aged 12-15 Years To Be Offered Covid Vaccine First Dose
Schoolchildren aged between 12 and 15 years will be offered a first dose of the Pfizer/BioNTech COVID-19 vaccine starting next week, the UK government has announced after the country's Chief Medical Officers gave their go-ahead for the jabs for young
-
COVID-19 Has More Blood Clot Threat Than Vaccines, Says UK Study: Report
A coronavirus infection presents a much higher risk of developing a blood clot than the first dose of either the Oxford/AstraZeneca or the Pfizer/BioNTech jab, a large study led by the University of Oxford said on Friday.
-
Blood Clot Risk Much Higher From Covid Than With Vaccines: UK Study
Covid-19 patients face a much higher risk of developing blood clots than those vaccinated with AstraZeneca Plc or Pfizer Inc.'s shots, according to a large U.K. study.
-
Protection From Pfizer, AstraZeneca Jabs Wanes Within 6 Months: UK Study
Protection against COVID-19 offered by two doses of the Pfizer/BioNTech and the Oxford/AstraZeneca coronavirus vaccines begins to fade within six months, underscoring the need for booster shots, according to researchers in Britain.
-
After Covid In Younger Groups, UK To Offer Shots To 16 And 17 Year-Olds
Britain will offer all 16 and 17 year olds their first dose of Pfizer COVID-19 vaccine, Britain's vaccine advisers said on Wednesday, extending eligibility of the shots to children beyond the clinically vulnerable.
-
Two Doses Mostly Prevent Hospitalisation With Delta Variant: UK Body
Two doses of COVID-19 vaccines are "highly effective" in preventing hospital admission with the Delta variant, Public Health England said on Monday.
-
Pfizer Vaccine For 12 To 15-Year-Olds Approved By UK Regulator
Britain's medicines regulator said Friday the Pfizer/BioNTech vaccine is safe for adolescents aged 12 to 15 after a "rigorous review", following similar assessments in the European Union and United States.
-
Oxford, Pfizer Vaccines 80% Effective On Variant Found In India: Study
Two doses from either the Oxford/AstraZeneca or the Pfizer vaccine are over 80 per cent effective in preventing infection from the B1.617.2 variant of COVID-19, first discovered in India, a new UK government study has reportedly found.
-
UK Approves Covid Jab For Under-12s As New Daily Cases Top 1 Lakh
British regulators on Wednesday approved Pfizer's Covid-19 vaccine for use in children aged five to 11, as the country reported more than 100,000 new daily cases for the first time as Omicron surged.
-
Mixing Covid Vaccines Is Effective In Study on Pfizer, AstraZeneca
Mixing other vaccines with those from AstraZeneca Plc or Pfizer Inc. offers at least as effective protection against Covid-19 as giving two doses of the same shots, a UK study found.
-
UK Schoolchildren Aged 12-15 Years To Be Offered Covid Vaccine First Dose
Schoolchildren aged between 12 and 15 years will be offered a first dose of the Pfizer/BioNTech COVID-19 vaccine starting next week, the UK government has announced after the country's Chief Medical Officers gave their go-ahead for the jabs for young
-
COVID-19 Has More Blood Clot Threat Than Vaccines, Says UK Study: Report
A coronavirus infection presents a much higher risk of developing a blood clot than the first dose of either the Oxford/AstraZeneca or the Pfizer/BioNTech jab, a large study led by the University of Oxford said on Friday.
-
Blood Clot Risk Much Higher From Covid Than With Vaccines: UK Study
Covid-19 patients face a much higher risk of developing blood clots than those vaccinated with AstraZeneca Plc or Pfizer Inc.'s shots, according to a large U.K. study.
-
Protection From Pfizer, AstraZeneca Jabs Wanes Within 6 Months: UK Study
Protection against COVID-19 offered by two doses of the Pfizer/BioNTech and the Oxford/AstraZeneca coronavirus vaccines begins to fade within six months, underscoring the need for booster shots, according to researchers in Britain.
-
After Covid In Younger Groups, UK To Offer Shots To 16 And 17 Year-Olds
Britain will offer all 16 and 17 year olds their first dose of Pfizer COVID-19 vaccine, Britain's vaccine advisers said on Wednesday, extending eligibility of the shots to children beyond the clinically vulnerable.
-
Two Doses Mostly Prevent Hospitalisation With Delta Variant: UK Body
Two doses of COVID-19 vaccines are "highly effective" in preventing hospital admission with the Delta variant, Public Health England said on Monday.
-
Pfizer Vaccine For 12 To 15-Year-Olds Approved By UK Regulator
Britain's medicines regulator said Friday the Pfizer/BioNTech vaccine is safe for adolescents aged 12 to 15 after a "rigorous review", following similar assessments in the European Union and United States.
-
Oxford, Pfizer Vaccines 80% Effective On Variant Found In India: Study
Two doses from either the Oxford/AstraZeneca or the Pfizer vaccine are over 80 per cent effective in preventing infection from the B1.617.2 variant of COVID-19, first discovered in India, a new UK government study has reportedly found.
